Sanofi-Aventis 2Q 2Q Revenues: $10.4 billion (+11%) 2Q Earnings: $3.2 billion (+29%) YTD Revenues: $20.4 billion (+7%) YTD Earnings: $6.2 billion (+22%) Comments: Pharmaceutical sales were up 7% to $9.4 billion. Lantus sales were up 26% to $1.1 billion. Lovenox sales were up 13% to $1.1 billion. Taxotere sales were $820 million (+11%). Plavix sales were up 5% to $989 million. Eloxatin sales were down 4% to $496 million. Sales in the U.S. and Europe were up 5%, and 20% in emerging ...